Metigalen

Methylprednisolone aceponate, the active ingredient in Metigalen, is a potent corticosteroid presented as a topical formulation for dermatological use. It exerts anti‑inflammatory and immunosuppressive actions to manage conditions such as psoriasis, atopic dermatitis and eczema, and is prescribed for patients requiring localized steroid therapy under medical supervision in clinical practice and across various age groups and severity levels.

GNH USA supplies Metigalen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on reliable quality, regulatory compliance and timely delivery to meet the needs of healthcare providers across multiple regions.

Metigalen, a topical corticosteroid, is used to treat inflammatory skin disorders by reducing local immune activity.

- Psoriasis: reduces scaling, erythema and plaque thickness. - Atopic dermatitis: alleviates itch and inflammation, improving skin barrier function. - Eczema: controls flare‑ups and minimizes lesion formation.

Topical corticosteroids may cause local and systemic adverse reactions.

Common Side Effects: - Skin irritation or burning sensation. - Pruritus or itching at the application site. - Dryness or peeling of the skin. - Folliculitis or mild erythema.

Serious or Rare Side Effects: - Adrenal suppression with extensive use. - Severe allergic reactions such as angioedema or anaphylaxis. - Skin atrophy, striae or telangiectasia. - Secondary bacterial, fungal or viral infection. - Systemic corticosteroid effects (e.g., hyperglycemia, hypertension). - Delayed wound healing.

Metigalen should be used with caution and under medical guidance.

- Assess skin integrity: avoid application on infected, ulcerated or open wounds. - Limit duration: use for the shortest effective period to minimize atrophy risk. - Apply thin layer: follow prescriber instructions regarding amount. - Avoid occlusion: do not cover treated area with airtight dressings unless directed. - Monitor for systemic effects: watch for signs of adrenal suppression, especially with large‑area or prolonged use. - Store at room temperature: keep in the original container, protect from moisture and light.

Topical corticosteroids can interact with systemic or topical agents.

Major Interactions (Avoid): - Systemic corticosteroids: additive glucocorticoid effect may increase systemic exposure. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local steroid concentrations. - Live vaccines: reduced efficacy when applied to extensive skin areas.

Moderate Interactions (Monitor Closely): - NSAIDs applied nearby: increased risk of skin irritation. - Antihistamines: may conceal early signs of local irritation. - Diabetic agents: monitor blood glucose if extensive application leads to systemic absorption.